Burning Rock Biotech (BNR) Total Non-Current Liabilities (2019 - 2025)

Burning Rock Biotech's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $5.4 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 1.15% year-over-year to $5.4 million; the TTM figure through Dec 2025 stood at $5.4 million (up 1.15% YoY), while the FY2025 annual figure was $5.5 million, up 4.24% from the prior year.
• Total Non-Current Liabilities was $5.4 million for Q4 2025 at Burning Rock Biotech, up from $3.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $11.8 million in Q2 2024 to a low of $1.1 million in Q4 2023.
• Historically, Total Non-Current Liabilities has averaged $6.2 million across 5 years, with a median of $5.3 million in 2025.
• The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities surged 12797.23% in 2021, then plunged 87.88% in 2023.
• A 5-year view of Total Non-Current Liabilities shows it stood at $9.6 million in 2021, then slumped by 73.99% to $2.5 million in 2022, then tumbled by 54.02% to $1.1 million in 2023, then soared by 365.17% to $5.3 million in 2024, then gained by 1.15% to $5.4 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $5.4 million (Q4 2025), $3.9 million (Q3 2025), and $4.3 million (Q2 2025), per Business Quant data.